Journals / Türk Geriatri Dergisi / 2014 / Cilt: 17 - Sayı: 2

İLK YAKINMASI İŞİTME KAYBI OLAN HASTADA KEMİ/İN PAGET HASTALI/I TANISI

A CASE OF PAGET'S DISEASE OF THE BONEPRESENTED WITH HEARING LOSS AS THEFIRST SYMPTOM

Pages
205–209
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Three months later, heralkaline phosphatase level had returned to the normal range, and audiologic examinationshowed a mild improvement in hearing

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A67-year-old woman presented to the audiology clinic with a complaint of bilateral hearing lossover the past two years.
📊
Key Findings & Data:Routine biochemical screening showed an alkaline phosphatase levelof 381 U/L, and she was referred to our endocrinology unit.
💡
Conclusion & Impact:Three months later, heralkaline phosphatase level had returned to the normal range, and audiologic examinationshowed a mild improvement in hearing
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A67-year-old woman presented to the audiology clinic with a complaint of bilateral hearing lossover the past two years. Routine biochemical screening showed an alkaline phosphatase levelof 381 U/L, and she was referred to our endocrinology unit. Her vitamin D and parathyroid hormone levels, as well as thyroid, liver and kidney function test results, were within normal ranges.Cranial x-ray radiography showed an increase in the diploe distance and a sclerotic pattern in thecalvarium; while whole body bone scintigraphy demonstrated a diffuse increase in radioactivesubstance involvement of the calvarium. Serum osteocalcin and spot urinary deoxypyridinolinelevels were increased. The patient was diagnosed with Paget's disease with hearing loss as thefirst symptom, and she was started taking zoledronic acid treatment. Three months later, heralkaline phosphatase level had returned to the normal range, and audiologic examinationshowed a mild improvement in hearing

Özet

Altmış yedi yaşında kadın hasta, her iki kulakta işitme kaybı nedeniyle odyoloji polikliniğinebaşvurdu. İki yıldır şikayeti olan hastanın rutin serum biyokimya incelemesinde alkalen fosfataz değerinin 381 U/L olması üzerine endokrinoloji ünitemize yönlendirildi. Hastanın vitamin D,parathormon, tiroid fonksiyon testleri, karaciğer fonksiyon testleri, böbrek fonksiyon testleri normal sınırlar içindeydi. Hastanın kranial grafisinde; diploe mesafesinde artış, kalvaryumda sklerotikgörünüm ve tüm vücut kemik sintigrafisinde; kalvaryumda diffüz tarzda artmış radyoaktif maddetutulumu izlendi. Serum osteokalsin ve spot idrarda deoksipridinolin düzeyleri yüksek saptandı.İşitme kaybının ilk semptom olarak görüldüğü hastaya mevcut bulgular ile kemiğin paget hastalığıtanısı ile zolendronik asit tedavisi verildi. Tedaviden üç ay sonraki kontrolünde, alkalen fosfatazdeğerinde normal düzeye gerileme ve odyolojik incelemede hafif düzeyde bir düzelme izlendi

🔖

Cite This Article

GEDİK, G. K., BULUT, S., BALDANE, S., KEBAPCILAR, L., İPEKÇİ, S. H., BALDANE, E. G. (2022). İLK YAKINMASI İŞİTME KAYBI OLAN HASTADA KEMİ/İN PAGET HASTALI/I TANISI. Türk Geriatri Dergisi, Cilt: 17 - Sayı: 2, 205–209. https://ajindex.com/articles/614058

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Ralston SH, Layfield R. Pathogenesis of Paget disease of bone.Calcif Tissue Int 2012
  2. 91(2):97-113. (PMID:22543925). Cody JD, Singer FR, Roodman GD, et al. Genetic linkage ofPaget disease of the bone to chromosome 18q. Am J Hum Ge-net 1997
  3. 61(5):1117-22. (PMID:9345096). Rea S, Walsh J, Ward L, Magno A, et al. Sequestome 1 muta-tions in Paget's disease of bone in Australia: Prevalence, genoty-pe/phenotype correlation, and a novel non-UBA domain muta-tion [P364S] associated with increased NF-B signaling withoutloss of ubiquitin binding. J Bone Miner Res 2009
  4. 24(7):1216-23. (PMID:19257822). Young CA, Fraser FD, Mackenzie IC. Detection of hearing im-pairment and handicap in Paget's disease of bone using a simp-le scoring system: A case control study. Bone 2007
  5. 40(1):189-93. (PMID:16962839) Langston AL, Ralston SH. Management of Paget's disease of bo- ne. Rheumatology 2004
  6. 43(8):955-9. (PMID:15187244). Van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Coo- per C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002
  7. 17(3):465-71. (PMID:11878305). Monsell EM. The mechanism of hearing loss in Paget's disease of bone. Laryngoscope 2004
  8. 114(4):598-606. (PMID:15064610). Donáth J, Krasznai M, Fornet B, Gergely P Jr, Poór G. Effect of bisphosphonate treatment in patients with Paget's disease of the skull. (PMID:12923287). Reid IR, Hosking DJ. Bisphosphonates in Paget's disease. Bo- ne 2011
  9. 49(1):89-94. (PMID:20832512).